SGHT
Sight Sciences Inc
NASDAQ: SGHT · HEALTHCARE · MEDICAL DEVICES
$8.53
-5.54% today
Updated 2026-10-02
Market cap
$491.94M
P/E ratio
—
P/S ratio
5.90x
EPS (TTM)
$-0.55
Dividend yield
—
52W range
$3 – $9
Volume
0.3M
Sight Sciences Inc (SGHT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$8.53
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$7.94
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -35.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.